BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 15123616)

  • 1. Crystal structure of the Toll/interleukin-1 receptor domain of human IL-1RAPL.
    Khan JA; Brint EK; O'Neill LA; Tong L
    J Biol Chem; 2004 Jul; 279(30):31664-70. PubMed ID: 15123616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains.
    Xu Y; Tao X; Shen B; Horng T; Medzhitov R; Manley JL; Tong L
    Nature; 2000 Nov; 408(6808):111-5. PubMed ID: 11081518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An extensively associated dimer in the structure of the C713S mutant of the TIR domain of human TLR2.
    Tao X; Xu Y; Zheng Y; Beg AA; Tong L
    Biochem Biophys Res Commun; 2002 Nov; 299(2):216-21. PubMed ID: 12437972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structures of the Toll/Interleukin-1 receptor (TIR) domains from the Brucella protein TcpB and host adaptor TIRAP reveal mechanisms of molecular mimicry.
    Snyder GA; Deredge D; Waldhuber A; Fresquez T; Wilkins DZ; Smith PT; Durr S; Cirl C; Jiang J; Jennings W; Luchetti T; Snyder N; Sundberg EJ; Wintrode P; Miethke T; Xiao TS
    J Biol Chem; 2014 Jan; 289(2):669-79. PubMed ID: 24275656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural complementarity of Toll/interleukin-1 receptor domains in Toll-like receptors and the adaptors Mal and MyD88.
    Dunne A; Ejdeback M; Ludidi PL; O'Neill LA; Gay NJ
    J Biol Chem; 2003 Oct; 278(42):41443-51. PubMed ID: 12888566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interleukin 1 (IL-1) receptor accessory protein Toll/IL-1 receptor domain: analysis of putative interaction sites in vitro mutagenesis and molecular modeling.
    Radons J; Dove S; Neumann D; Altmann R; Botzki A; Martin MU; Falk W
    J Biol Chem; 2003 Dec; 278(49):49145-53. PubMed ID: 13679373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactive sites in the MyD88 Toll/interleukin (IL) 1 receptor domain responsible for coupling to the IL1beta signaling pathway.
    Li C; Zienkiewicz J; Hawiger J
    J Biol Chem; 2005 Jul; 280(28):26152-9. PubMed ID: 15849357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of the binding mode of Toll/interleukin-1 receptor (TIR) domain proteins during TLR2 signaling.
    Nada M; Ohnishi H; Tochio H; Kato Z; Kimura T; Kubota K; Yamamoto T; Kamatari YO; Tsutsumi N; Shirakawa M; Kondo N
    Mol Immunol; 2012 Oct; 52(3-4):108-16. PubMed ID: 22673208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family.
    Martin MU; Wesche H
    Biochim Biophys Acta; 2002 Nov; 1592(3):265-80. PubMed ID: 12421671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4.
    Burns K; Janssens S; Brissoni B; Olivos N; Beyaert R; Tschopp J
    J Exp Med; 2003 Jan; 197(2):263-8. PubMed ID: 12538665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bioinformatic approach to the identification of bacterial proteins interacting with Toll-interleukin 1 receptor-resistance (TIR) homology domains.
    Turner JD
    FEMS Immunol Med Microbiol; 2003 Jun; 37(1):13-21. PubMed ID: 12770755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanisms.
    Qin J; Qian Y; Yao J; Grace C; Li X
    J Biol Chem; 2005 Jul; 280(26):25233-41. PubMed ID: 15866876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of TIR domain of TLR6 reveals novel dimeric interface of TIR-TIR interaction for toll-like receptor signaling pathway.
    Jang TH; Park HH
    J Mol Biol; 2014 Sep; 426(19):3305-3313. PubMed ID: 25088687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JNK-interacting protein 3 associates with Toll-like receptor 4 and is involved in LPS-mediated JNK activation.
    Matsuguchi T; Masuda A; Sugimoto K; Nagai Y; Yoshikai Y
    EMBO J; 2003 Sep; 22(17):4455-64. PubMed ID: 12941697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
    Horng T; Barton GM; Flavell RA; Medzhitov R
    Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential involvement of BB loops of toll-IL-1 resistance (TIR) domain-containing adapter proteins in TLR4- versus TLR2-mediated signal transduction.
    Toshchakov VU; Basu S; Fenton MJ; Vogel SN
    J Immunol; 2005 Jul; 175(1):494-500. PubMed ID: 15972684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional evidence for the role of the TLR2 DD loop in TLR1/TLR2 heterodimerization and signaling.
    Gautam JK; Ashish ; Comeau LD; Krueger JK; Smith MF
    J Biol Chem; 2006 Oct; 281(40):30132-42. PubMed ID: 16893894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into TIR domain specificity of the bridging adaptor Mal in TLR4 signaling.
    Lin Z; Lu J; Zhou W; Shen Y
    PLoS One; 2012; 7(4):e34202. PubMed ID: 22485159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The STIR-domain superfamily in signal transduction, development and immunity.
    Novatchkova M; Leibbrandt A; Werzowa J; Neubüser A; Eisenhaber F
    Trends Biochem Sci; 2003 May; 28(5):226-9. PubMed ID: 12765832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
    Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
    Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.